Increlex Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Increlex: Solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MECASERMIN is a man-made growth factor. It is used to increase growth in children who are short for their age. It is only for children whose bodies do not make enough growth factor.

Similar Brand Name Drugs : Iplex: Solution for injection (36mg)
In-Depth Information

Increlex 10mg/ml Solution For Injection

NDC: 150541040
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Growth Hormone (GH) Gene Deletion, Primary Insulin-like Growth Factor (IGF-1) Deficiency

Sometimes used for but not FDA approved for the following conditions:
Amyotrophic Lateral Sclerosis (ALS)

Storage Information
Discard 30 days after first use
Protect from light
Store unopened containers in refrigerator (36 to 46 degrees F)
Store opened container in refrigerator (between 36 to 46 degrees F) for up to 30 days
Protect from freezing
Increlex 10mg/ml Solution For Injection

Reported Side Effects for Increlex 10mg/ml Solution For Injection

Anaphylactoid Reactions Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Angioedema Incidence:
<1.0%*
Severity: SEVERE
Onset: RAPID
Swelling Incidence:
1.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
2.0-87.0%*
Severity: MILD
Onset: RAPID
Headache Incidence:
5.0-64.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
>5.0%*
Severity: MILD
Onset: EARLY
Convulsions Incidence:
>5.0%*
Severity: SEVERE
Onset: DELAYED
Muscle And/Or Bone Pain Incidence:
>6.0%*
Severity: MILD
Onset: EARLY
Retinopathy Incidence:
7.0%*
Severity: SEVERE
Onset: DELAYED
Sinus Infection Incidence:
8.0-13.0%*
Severity: MILD
Onset: DELAYED
Joint Pain Incidence:
>10.0%*
Severity: MILD
Onset: DELAYED
Enlarged Lymph Nodes Incidence:
15.0%*
Severity: MODERATE
Onset: DELAYED
Low Blood Sugar Incidence:
42.0-47.0%*
Severity: MODERATE
Onset: EARLY
Antibody Formation Incidence:
61.0%*
Severity: MODERATE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Increlex

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5